js015
mAbexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2023 (NCT05770310)
Timeline
Indications
Mechanism of action
- Dickkopf-related protein 1INHIBITOR
DKK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06885385 | Phase 2 | Apr 23, 2025 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT06370754 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2024 | Fudan University |
| NCT06139211 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2023 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT05770310 | Phase 1 | Feb 1, 2023 | Shandong University, Shanghai Junshi Bioscience Co.,Ltd., Shanghai Oriental Hospital, Sponsor GmbH |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 3 | 3 | 2 | 2023 |
| Sponsor GmbH | Academic/Hospital | 2 | 0 | 2 | 2023 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Shandong University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Shanghai Oriental Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
5 organizations
Page 1 / 1